Chinese pharmaceutical company announced that it has produced a vaccine for the swine flu virus that is designed to begin working after one dose.
Clinical trials have produced "positive" results, said Sinovac, the latest company to announce progress in making a vaccine against the A(H1N1) virus ahead of an expected second wave as the northern hemisphere winter approaches.
Panic Over Swine Flu Subsides in Mumbai
After the initial panic surrounding Swine Flu, the people of Mumbai mustered enough courage and went to watch their favourite movie in the multiplexes, which reopened after being shut for three days.
Advertisement
"The analysis of the clinical trial results showed that the A(H1N1) vaccine developed by Sinovac induces good immunogenicity after one dose," it said in a statement.
The clinical trials began last month and were completed on August 15 in Beijing, with some 1,614 participants aged three and over.
"After receiving one shot of the vaccine, none of the volunteers participating in Sinovac's clinical trials exhibited any signs of severe adverse reactions," it said.
![Scared Public Take to Facemasks to Prevent Swine Flu]( "Scared Public Take to Facemasks to Prevent Swine Flu")
People in Kolkata are taking precautions against swine flu or H1N1 influenza as the number of cases is on rise in the country.
Any adverse reactions were "all mild and transient, with pain at the site of injection as the most common symptom," it added.
Sinovac chief Weidong Yin said the company plans to take the next steps in bringing the vaccine to market "as soon as possible," while fully ensuring "the safety and immunogenicity of the vaccine."
British pharmaceuticals group GlaxoSmithKline said last week that it had begun clinical trials in Germany of a vaccine to combat the swine flu pandemic, with results expected from next month.
Source: AFP
SAV
"After receiving one shot of the vaccine, none of the volunteers participating in Sinovac's clinical trials exhibited any signs of severe adverse reactions," it said.
Scared Public Take to Facemasks to Prevent Swine Flu
People in Kolkata are taking precautions against swine flu or H1N1 influenza as the number of cases is on rise in the country.
Advertisement
Any adverse reactions were "all mild and transient, with pain at the site of injection as the most common symptom," it added.
Sinovac chief Weidong Yin said the company plans to take the next steps in bringing the vaccine to market "as soon as possible," while fully ensuring "the safety and immunogenicity of the vaccine."
British pharmaceuticals group GlaxoSmithKline said last week that it had begun clinical trials in Germany of a vaccine to combat the swine flu pandemic, with results expected from next month.
Source: AFP
SAV
Netherlands Plans to Immunize Most at Risk Against Swine Flu
The Netherlands will from October offer vaccinations to about five to six million people considered to be most at risk of complications from swine flu, the health ministry said on Tuesday.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest General Health News
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.